Development and external validation of a melanoma risk prediction model based on self-assessed risk factors

JAMA Dermatology

Volumn 152, Issue 8, 2016, Pages 889-896

  Vuong, Kylie ^a,b   Armstrong, Bruce K ^a   Weiderpass, Elisabete ^c,d,e,f   Lund, Eiliv ^c   Adami, Hans Olov ^d,g   Veierod, Marit B ^h   Barrett, Jennifer H ⁱ   Davies, John R ⁱ   Bishop, D Timothy ⁱ   Whiteman, David C ^j   Olsen, Catherine M ^j   Hopper, John L ^k   Mann, Graham J ^l   Cust, Anne E ^a,l   McGeechan, Kevin ^a   Aitken, Joanne F ^m,n,o,p   Giles, Graham G ^k,q,r   Kefford, Richard F ^l,s,t   Schmid, Helen ^l   Jenkins, Mark A ^k  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF TROMSØ   (Norway)

^d KAROLINSKA INSTITUTE   (Sweden)

^e CANCER REGISTRY OF NORWAY   (Norway)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^h UNIVERSITY OF OSLO   (Norway)

ⁱ UNIVERSITY OF LEEDS   (United Kingdom)

^j QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^k UNIVERSITY OF MELBOURNE   (Australia)

^l UNIVERSITY OF SYDNEY   (Australia)

^m CANCER COUNCIL QUEENSLAND   (Australia)

ⁿ GRIFFITH UNIVERSITY   (Australia)

^o QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^p UNIVERSITY OF SOUTHERN QUEENSLAND   (Australia)

^q MONASH UNIVERSITY   (Australia)

^r CANCER EPIDEMIOLOGY CENTRE   (Australia)

^s MACQUARIE UNIVERSITY   (Australia)

^t WESTMEAD HOSPITAL   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CALIBRATION; CANCER RISK; CONTROLLED STUDY; CUTANEOUS MELANOMA; FAMILY HISTORY; FIRST DEGREE RELATIVE; HAIR COLOR; HUMAN; MAJOR CLINICAL STUDY; MATHEMATICAL MODEL; NEVUS; NON MELANOMA SKIN CANCER; PREDICTION; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; VALIDATION STUDY; ADOLESCENT; ADVERSE EFFECTS; AGED; AREA UNDER THE CURVE; AUSTRALIA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE CONTROL STUDY; CHILD; FEMALE; GENETICS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROCEDURES; RISK ASSESSMENT; SELF EVALUATION; SKIN NEOPLASMS; STATISTICAL MODEL; SWEDEN; ULTRAVIOLET RADIATION; UNITED KINGDOM; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; AUSTRALIA; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHILD; DIAGNOSTIC SELF EVALUATION; FEMALE; HAIR COLOR; HUMANS; LOGISTIC MODELS; MALE; MELANOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEVUS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SKIN NEOPLASMS; SWEDEN; ULTRAVIOLET RAYS; UNITED KINGDOM; YOUNG ADULT;

EID: 84982163221     PISSN: 21686068     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamadermatol.2016.0939     Document Type: Article

References (46)

1. Erdmann F, Lortet-Tieulent J, Schüz J, et al. International trends in the incidence of malignant melanoma 1953-2008-are recent generations at higher or lower risk? Int J Cancer. 2013;132(2):385-400.
2. Stanton WR, Janda M, Baade PD, Anderson P. Primary prevention of skin cancer: a review of sun protection in Australia and internationally. Health Promot Int. 2004;19(3):369-378.
3. Ahmed H, Naik G, Willoughby H, Edwards AG. Communicating risk. BMJ. 2012;344:e3996.
4. Freedman AN, Seminara D, Gail MH, et al. Cancer risk prediction models: a workshop on development, evaluation, and application. J Natl Cancer Inst. 2005;97(10):715-723.
5. Vuong K, McGeechan K, Armstrong BK, Cust AE. Risk prediction models for incident primary cutaneous melanoma: a systematic review. JAMA Dermatol. 2014;150(4):434-444.
6. Olsen CM, Neale RE, Green AC, Webb PM, Whiteman DC; QSkin Study; Epigene Study. Independent validation of six melanoma risk prediction models. J Invest Dermatol. 2015;135(5): 1377-1384.
7. Collins GS, de Groot JA, Dutton S, et al. External validation of multivariable prediction models: a systematic review of methodological conduct and reporting. BMC Med Res Methodol. 2014;14:40.
8. Cust AE, Schmid H, Maskiell JA, et al. Population-based, case-control-family design to investigate genetic and environmental influences on melanoma risk: Australian Melanoma Family Study. Am J Epidemiol. 2009;170(12):1541-1554.
9. English DR, Armstrong BK. Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia. Br Med J (Clin Res Ed). 1988;296(6632):1285-1288.
10. Newton-Bishop JA, Chang YM, Iles MM, et al. Melanocytic nevi, nevus genes, and melanoma risk in a large case-control study in the United Kingdom. Cancer Epidemiol Biomarkers Prev. 2010;19(8): 2043-2054.
11. Newton-Bishop JA, Chang YM, Elliott F, et al. Relationship between sun exposure and melanoma risk for tumours in different body sites in a large case-control study in a temperate climate. Eur J Cancer. 2011;47(5):732-741.
12. Kvaskoff M, Pandeya N, Green AC, et al. Site-specific determinants of cutaneous melanoma: a case-case comparison of patients with tumors arising on the head or trunk. Cancer Epidemiol Biomarkers Prev. 2013;22(12):2222-2231.
13. Olsen CM, Green AC, Neale RE, et al; QSkin Study. Cohort profile: the QSkin Sun and Health Study. Int J Epidemiol. 2012;41(4):929-929i.
14. Roswall N, Sandin S, Adami HO, Weiderpass E. Cohort profile: the Swedish Women's Lifestyle and Health cohort [published online June 10, 2015]. Int J Epidemiol. doi:10.1093/ije/dyv089.
15. Veierød MB, Adami HO, Lund E, Armstrong BK, Weiderpass E. Sun and solarium exposure and melanoma risk: effects of age, pigmentary characteristics, and nevi. Cancer Epidemiol Biomarkers Prev. 2010;19(1):111-120.
16. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. common and atypical naevi. Eur J Cancer. 2005;41(1):28-44.
17. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: II. sun exposure. Eur J Cancer. 2005;41 (1):45-60.
18. Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: III. family history, actinic damage and phenotypic factors. Eur J Cancer. 2005;41(14): 2040-2059.
19. Cust AE, Armstrong BK, Goumas C, et al. Sunbed use during adolescence and early adulthood is associated with increased risk of early-onset melanoma. Int J Cancer. 2011;128(10): 2425-2435.
20. Chang YM, Barrett JH, Bishop DT, et al. Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol. 2009;38(3):814-830.
21. Vergouwe Y, Royston P, Moons KG, Altman DG. Development and validation of a prediction model with missing predictor data: a practical approach. J Clin Epidemiol. 2010;63(2):205-214.
22. Gail MH, Brinton LA, Byar DP, et al. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81(24):1879-1886.
23. Bruzzi P, Green SB, Byar DP, Brinton LA, Schairer C. Estimating the population attributable risk for multiple risk factors using case-control data. Am J Epidemiol. 1985;122(5):904-914.
24. Steyerberg EW. Clinical Prediction Models. New York, NY: Springer; 2010.
25. Veierød MB, Weiderpass E, Thörn M, et al. A prospective study of pigmentation, sun exposure, and risk of cutaneous malignant melanoma in women. J Natl Cancer Inst. 2003;95(20):1530-1538.
26. Steyerberg EW, Vergouwe Y. Towards better clinical prediction models: seven steps for development and an ABCD for validation. Eur Heart J. 2014;35(29):1925-1931.
27. Vickers AJ, Elkin EB. Decision curve analysis: a novelmethod for evaluating prediction models. Med Decis Making. 2006;26(6):565-574.
28. Royston P, Moons KG, Altman DG, Vergouwe Y. Prognosis and prognostic research: developing a prognostic model. BMJ. 2009;338:b604.
29. Bender R, Lange S. Adjusting for multiple testing-when and how? J Clin Epidemiol. 2001;54 (4):343-349.
30. Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ. 2015;350: g7594.
31. Pepe MS, Fan J, Seymour CW, Li C, Huang Y, Feng Z. Biases introduced by choosing controls to match risk factors of cases in biomarker research. Clin Chem. 2012;58(8):1242-1251.
32. Usher-Smith JA, Emery J, Kassianos AP, Walter FM. Risk prediction models for melanoma: a systematic review. Cancer Epidemiol Biomarkers Prev. 2014;23(8):1450-1463.
33. Fortes C, Mastroeni S, Bakos L, et al. Identifying individuals at high risk of melanoma: a simple tool. Eur J Cancer Prev. 2010;19(5):393-400.
34. Cust AE, Goumas C, Vuong K, et al. MC1R genotype as a predictor of early-onset melanoma, compared with self-reported and physician-measured traditional risk factors: an Australian case-control-family study. BMC Cancer. 2013;13:406.
35. Cust AE, Pickles KM, Goumas C, et al. Accuracy of self-reported nevus and pigmentation phenotype compared with clinical assessment in a population-based study of young Australian adults. Cancer Epidemiol Biomarkers Prev. 2015;24(4):736-743.
36. Anothaisintawee T, Teerawattananon Y, Wiratkapun C, Kasamesup V, Thakkinstian A. Risk prediction models of breast cancer: a systematic review of model performances. Breast Cancer Res Treat. 2012;133(1):1-10.
37. Win AK, Macinnis RJ, Hopper JL, Jenkins MA. Risk prediction models for colorectal cancer: a review. Cancer Epidemiol Biomarkers Prev. 2012;21 (3):398-410.
38. Usher-Smith JA, Walter FM, Emery JD, Win AK, Griffin SJ. Risk prediction models for colorectal cancer: a systematic review. Cancer Prev Res (Phila). 2016;9(1):13-26.http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list-uids=24895414&dopt=Abstract
39. Spitz MR, Etzel CJ, Dong Q, et al. An expanded risk prediction model for lung cancer. Cancer Prev Res (Phila). 2008;1(4):250-254.
40. Lughezzani G, Briganti A, Karakiewicz PI, et al. Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. Eur Urol. 2010;58(5):687-700.
41. Siontis GC, Tzoulaki I, Castaldi PJ, Ioannidis JP. External validation of new risk prediction models is infrequent and reveals worse prognostic discrimination. J Clin Epidemiol. 2015;68(1):25-34.
42. Kramer AA, Zimmerman JE. Assessing the calibration of mortality benchmarks in critical care: the Hosmer-Lemeshow test revisited. Crit Care Med. 2007;35(9):2052-2056.
43. Davies JR, Chang YM, Bishop DT, et al. Development and validation of a melanoma risk score based on pooled data from 16 case-control studies. Cancer Epidemiol Biomarkers Prev. 2015;24 (5):817-824.
44. Collins GS, Altman DG. Identifying patients with undetected colorectal cancer: an independent validation of QCancer (colorectal). Br J Cancer. 2012;107(2):260-265.
45. Li K, Hüsing A, Sookthai D, et al. Selecting high-risk individuals for lung cancer screening-a prospective evaluation of existing risk models and eligibility criteria in the German EPIC cohort. Cancer Prev Res (Phila). 2015;8(9):777-785.
46. Foley RW, Gorman L, Sharifi N, et al. Improving multivariable prostate cancer risk assessment using the Prostate Health Index. BJU Int. 2016;117(3): 409-417.